Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 650–651 | Cite as

ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend?

  • Olga Kantor
  • Katharine Yao
ASO Author Reflections



There are no conflicts of interest.


  1. 1.
    Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008;26:778–85.CrossRefGoogle Scholar
  2. 2.
    Mougalian SS, Soulos PR, Killelea BK, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. 2015;121:2544–52.CrossRefGoogle Scholar
  3. 3.
    Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150:9–16.CrossRefGoogle Scholar
  4. 4.
    Kantor O, Ajmani G, Wang CH, et al. The shifting paradigm for breast cancer surgery in patients undergoing neoadjuvant chemotherapy. Ann Surg Oncol. 2008;25:164–72.CrossRefGoogle Scholar
  5. 5.
    Jagsi R, Hawley ST, Griffith KA, et al. Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg. 2017;152:274–82.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of ChicagoChicagoUSA
  2. 2.Department of SurgeryNorthShore University Health SystemEvanstonUSA
  3. 3.Pritzker School of MedicineUniversity of ChicagoChicagoUSA

Personalised recommendations